BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9506650)

  • 1. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
    Lindsay CA; Barton P; Lawless S; Kitchen L; Zorka A; Garcia J; Kouatli A; Giroir B
    J Pediatr; 1998 Feb; 132(2):329-34. PubMed ID: 9506650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.
    Prielipp RC; MacGregor DA; Butterworth JF; Meredith JW; Levy JH; Wood KE; Coursin DB
    Chest; 1996 May; 109(5):1291-301. PubMed ID: 8625682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass.
    De Hert SG; Moens MM; Jorens PG; Delrue GL; DePaep RJ; Vermeyen KM
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):264-71. PubMed ID: 7669958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
    Chang AC; Atz AM; Wernovsky G; Burke RP; Wessel DL
    Crit Care Med; 1995 Nov; 23(11):1907-14. PubMed ID: 7587268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery.
    Bailey JM; Levy JH; Kikura M; Szlam F; Hug CC
    Anesthesiology; 1994 Sep; 81(3):616-22. PubMed ID: 8092507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
    Benotti JR; Lesko LJ; McCue JE; Alpert JS
    Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
    Baruch L; Patacsil P; Hameed A; Pina I; Loh E
    Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone].
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.
    Hornik CP; Yogev R; Mourani PM; Watt KM; Sullivan JE; Atz AM; Speicher D; Al-Uzri A; Adu-Darko M; Payne EH; Gelber CE; Lin S; Harper B; Melloni C; Cohen-Wolkowiez M; Gonzalez D;
    J Clin Pharmacol; 2019 Dec; 59(12):1606-1619. PubMed ID: 31317556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failure.
    Woolfrey SG; Hegbrant J; Thysell H; Fox PA; Lendrem DW; Lockwood GF; Lasher K; Rogers J; Greenslade D
    J Pharm Pharmacol; 1995 Aug; 47(8):651-5. PubMed ID: 8583366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery.
    Butterworth JF; Hines RL; Royster RL; James RL
    Anesth Analg; 1995 Oct; 81(4):783-92. PubMed ID: 7574011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the hemodynamic and pharmacokinetic profile of intravenous milrinone in the anesthetized dog.
    Alousi AA; Iwan T; Edelson J; Biddlecome C
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):59-66. PubMed ID: 6721624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease.
    Borow KM; Come PC; Neumann A; Baim DS; Braunwald E; Grossman W
    Am J Cardiol; 1985 Apr; 55(9):1204-9. PubMed ID: 3984901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
    Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery.
    Ramamoorthy C; Anderson GD; Williams GD; Lynn AM
    Anesth Analg; 1998 Feb; 86(2):283-9. PubMed ID: 9459233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass.
    Kikura M; Levy JH; Michelsen LG; Shanewise JS; Bailey JM; Sadel SM; Szlam F
    Anesth Analg; 1997 Jul; 85(1):16-22. PubMed ID: 9212116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients.
    Girbes AR; Patten MT; McCloskey BV; Groeneveld AB; Hoogenberg K
    Intensive Care Med; 2000 Nov; 26(11):1685-9. PubMed ID: 11193277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma elimination of milrinone in rats in relation to its hemodynamic effects.
    Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
    J Pharm Sci; 1990 Mar; 79(3):236-9. PubMed ID: 2338634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.